
    
      ADROIT is an international, prospective, multicenter, observational, post-market study
      intended to collect worldwide long-term safety and effectiveness data on subjects implanted
      with market-released Abbott DBS systems in routine clinical practice.

      Subjects will be followed for 5 years after the initial programming visit.
    
  